Most of the LBD patients were taking cholinesterase inhibitor medication, which has been shown to result in faster RT in Parkinson's disease (Rowan et al., 2007), so may have reduced response latencies in subjects, although we did not see any differences in those patients taking such medication compared to those not on these agents. The gene discussed is BCHE; the disease is Parkinson disease.